carmustine has been researched along with Pulmonary Fibrosis in 52 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Delayed pulmonary toxicity syndrome, characterized by interstitial pneumonia and pulmonary fibrosis, is common following high-dose bischloroethylnitrosourea (BCNU) (carmustine, [1,3-bis (2-chloroethyl)-1-nitrosourea]) containing chemotherapeutic regimens." | 3.72 | Interferon-gamma for delayed pulmonary toxicity syndrome resistant to steroids. ( Brown, KK; Cool, CD; Jones, RB; Lynch, DA; Suratt, BT, 2003) |
| "Previously, we have reported in 1990 that 35% of carmustine treated patients (6 of 17) who survived childhood brain tumors died of pulmonary fibrosis between 2 and 13 years after treatment." | 3.69 | Late carmustine lung fibrosis. Age at treatment may influence severity and survival. ( Gattamaneni, HR; Kalra, S; O'Driscoll, BR; Woodcock, AA, 1995) |
| "Carmustine (BCNU) is a cytotoxic drug which is a recognized cause of acute pulmonary fibrosis." | 3.68 | Chronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features. ( Gattamaneni, HR; O'Driscoll, BR; Taylor, PM; Woodcock, AA, 1991) |
| "We describe eight patients who developed interstitial pulmonary fibrosis following BCNU (carmustine) therapy for cerebral tumours." | 3.68 | Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma. ( Gattamaneini, HR; Hasleton, PS; Kalra, SJ; Lynch, P; O'Driscoll, BR; Poulter, LW; Webster, A; Woodcock, AA, 1991) |
| "Carmustine (BCNU) is an anticancer drug known to produce pulmonary fibrosis as a side effect within three years of treatment." | 3.68 | Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. ( Gattameneni, HR; Hasleton, PS; O'Driscoll, BR; Poulter, LW; Taylor, PM; Woodcock, AA, 1990) |
| "A patient who had a pneumonectomy for lung carcinoma was treated with carmustine when brain metastases developed." | 3.66 | Pulmonary toxicity from carmustine (BCNU): a case report. ( Shah, S; Shane, SR; Weiss, RB, 1979) |
| "A 43-year-old man with metastatic malignant melanoma was treated with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in combination with imidazole carboxamide and hydroxyurea." | 3.65 | Pulmonary fibrosis after prolonged therapy with 1,3-bis (2-chloroethyl)-1-nitrosourea. ( Crittenden, D; Haut, A; Tranum, BL, 1977) |
| "No fatal complications or chronic pulmonary fibrosis was seen." | 2.68 | Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment. ( Chap, L; Glaspy, J; Levine, M; Lill, M; Norton, L; Shpiner, R, 1997) |
| "Pulmonary fibrosis is the end point of progressive functional disorder of respiratory mechanism and alveolo-capillary gas exchanges." | 2.66 | Nitrosourea derivatives-induced pulmonary toxicity in patients treated for malignant brain tumors. Early subclinical detection and its prevention. ( Butti, G; Gaetani, P; Knerich, R; Rossi, A; Silvani, V; Spanu, G, 1987) |
| "Diffuse pulmonary diseases seen in patients receiving chemotherapy have a wide variety of etiologies including infection, involvement with the underlying disease, injury from radiation or diagnostic agents, and toxicity from chemotherapeutic drugs." | 2.36 | Review: diagnosis of chemotherapy lung. ( Gamsu, G; Putman, CE; Sostman, HD, 1981) |
| " Additionally, medical records of 163 patients treated with BCNU for recurrent glioma WHO grade II to IV were retrospectively evaluated for BCNU-related side effects classified according to the National Cancer Institute Common Toxicity Criteria for Adverse Events (CTCAE) version 2." | 1.43 | Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients. ( Ahmadi, R; Bermejo, JL; Capper, D; Chatziaslanidou, D; Exner, J; Herold-Mende, C; Jungk, C; Unterberg, A; von Deimling, A, 2016) |
| "Bilateral upper lobe pulmonary fibrosis can be associated with chemotherapeutic drugs." | 1.32 | Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation. ( Leslie, KO; Muhm, JR; Parish, JM, 2003) |
| "In conclusion, pulmonary fibrosis can develop early and progress rapidly after the administration of high-dose BCNU." | 1.32 | Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-beta1 and cyclooxygenase-2. ( Chen, CL; Chiu, CF; Chow, KC; Liaw, YC; Shen, YC; Yeh, SP, 2004) |
| " The side effect of pulmonary fibrosis occurs in 20 to 30 percent of patients receiving this drug." | 1.29 | Carmustine toxicity presenting as a lobar infiltrate. ( Byron, WA; Lee, TH; Patterson, DL; Wiemann, MC, 1993) |
| " The 30-day LD50 for BCNU in male and female BALB/c mice was 52 and 46 mg/kg, respectively." | 1.27 | Enhanced oxygen toxicity following treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea. ( Kehrer, JP; Paraidathathu, T, 1984) |
| "She developed progressive, pulmonary fibrosis as a consequence of chemotherapy, which lead to her death." | 1.27 | Chemotherapy-induced fatal pulmonary fibrosis. ( Révész, T; Somló, P, 1984) |
| "Two patients treated for chronic myeloid leukemia with high doses of CCNU (1100 mg/m2 and 1240 mg/m2, respectively) developed a fatal pulmonary fibrosis." | 1.27 | Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia. ( Bernaudin, JF; Cordonnier, C; Lange, F; Mital, P; Rochant, H; Vernant, JP, 1983) |
| "The occurrence of pulmonary disease associated with long-term BCNU therapy is reported in two patients treated for astrocytoma grade II whose clinical presentations of pulmonary complications and corresponding tissue alterations showed striking differences." | 1.27 | BCNU (1,3-bis-(2-chloroethyl)-1-nitrosurea) lung. Drug-induced pulmonary changes. ( Banerji, B; Greenwald, ES; Koss, LG; Mitsudo, SM, 1984) |
| "All animals developed pulmonary fibrosis accompanied by formation of peribronchial and peribronchiolar foci of granulomatous tissue." | 1.27 | Sequential pathological changes induced in rats with the anti-cancer drug I, 3-bis (2-chloroethyl)-I-nitrosourea (BCNU). ( Boyd, MR; Gregg, M; Schuller, HM; Smith, AC, 1985) |
| "It is concluded that BCNU causes pulmonary fibrosis that is primarily but not necessarily dose-related and may not be reversible." | 1.26 | 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced pulmonary fibrosis. ( Bellot, P; Cohen, M; Fisher, ER; Jacobs, SA; Moore, PB; Selker, RG; Wald, M, 1980) |
| " The patient received a cumulative dosage of 1." | 1.26 | Pulmonary fibrosis: a complication of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy. ( Ryan, BR; Walters, TR, 1981) |
| "Both patients developed pulmonary fibrosis, which was visible in postmortem examination." | 1.26 | Pulmonary fibrosis following low-dose 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) therapy. ( Melato, M; Tuveri, G, 1980) |
| "Ten patients developed pulmonary fibrosis after bischloroethylnitrosourea (BCNU) therapy for malignancy." | 1.26 | Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU). ( Bartolucci, AA; Durant, JR; Langford, KH; Murad, TM; Norgard, MJ, 1979) |
| "A case of interstitial pulmonary fibrosis secondary to bischloronitrosourea (BCNU) in a 49-year-old man with carcinoma of the pancreas is reported." | 1.26 | Pulmonary toxicity of bischloronitrosourea: report of a case with transient response to corticosteroid therapy. ( Dalton, JF; Hastedt, R; Marshall, D; Raymond, LW; Richter, JE, 1979) |
| "A case is reported of a child with fatal pulmonary fibrosis following BCNU therapy." | 1.26 | Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy. ( Bailey, CC; Jones, PH; Marsden, HB, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (69.23) | 18.7374 |
| 1990's | 10 (19.23) | 18.2507 |
| 2000's | 5 (9.62) | 29.6817 |
| 2010's | 1 (1.92) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jungk, C | 1 |
| Chatziaslanidou, D | 1 |
| Ahmadi, R | 1 |
| Capper, D | 1 |
| Bermejo, JL | 1 |
| Exner, J | 1 |
| von Deimling, A | 1 |
| Herold-Mende, C | 1 |
| Unterberg, A | 1 |
| Helal, GK | 1 |
| Helal, OK | 1 |
| Parish, JM | 1 |
| Muhm, JR | 1 |
| Leslie, KO | 1 |
| Suratt, BT | 1 |
| Lynch, DA | 1 |
| Cool, CD | 1 |
| Jones, RB | 1 |
| Brown, KK | 1 |
| Shen, YC | 1 |
| Chiu, CF | 1 |
| Chow, KC | 1 |
| Chen, CL | 1 |
| Liaw, YC | 1 |
| Yeh, SP | 1 |
| Lohani, S | 1 |
| O'Driscoll, BR | 5 |
| Woodcock, AA | 5 |
| Sostman, HD | 1 |
| Putman, CE | 1 |
| Gamsu, G | 1 |
| Ginsberg, SJ | 1 |
| Comis, RL | 1 |
| Cohen, MH | 1 |
| Matthews, MJ | 1 |
| Weiss, RB | 3 |
| Poster, DS | 1 |
| Penta, JS | 1 |
| Kehrer, JP | 2 |
| Paraidathathu, T | 1 |
| Somló, P | 2 |
| Révész, T | 2 |
| Cordonnier, C | 1 |
| Vernant, JP | 1 |
| Mital, P | 1 |
| Lange, F | 1 |
| Bernaudin, JF | 1 |
| Rochant, H | 1 |
| Mitsudo, SM | 1 |
| Greenwald, ES | 1 |
| Banerji, B | 1 |
| Koss, LG | 1 |
| Wilson, KS | 1 |
| Brigden, ML | 1 |
| Alexander, S | 1 |
| Worth, A | 1 |
| Selker, RG | 1 |
| Jacobs, SA | 1 |
| Moore, PB | 1 |
| Wald, M | 1 |
| Fisher, ER | 1 |
| Cohen, M | 1 |
| Bellot, P | 1 |
| Klein, RC | 1 |
| Paddison, RM | 1 |
| Bardella, D | 1 |
| Beccati, D | 1 |
| Cruciani, G | 1 |
| Ryan, BR | 1 |
| Walters, TR | 1 |
| Melato, M | 1 |
| Tuveri, G | 1 |
| Patten, GA | 1 |
| Billi, JE | 1 |
| Rotman, HH | 1 |
| Kalra, S | 1 |
| Gattamaneni, HR | 2 |
| Patterson, DL | 1 |
| Wiemann, MC | 1 |
| Lee, TH | 1 |
| Byron, WA | 1 |
| Schmitz, N | 1 |
| Diehl, V | 1 |
| Chap, L | 1 |
| Shpiner, R | 1 |
| Levine, M | 1 |
| Norton, L | 1 |
| Lill, M | 1 |
| Glaspy, J | 1 |
| Bargon, G | 2 |
| Anger, B | 2 |
| Schreml, W | 2 |
| Kubanek, W | 1 |
| Heimpel, H | 2 |
| Durant, JR | 1 |
| Norgard, MJ | 1 |
| Murad, TM | 1 |
| Bartolucci, AA | 1 |
| Langford, KH | 1 |
| Richter, JE | 1 |
| Hastedt, R | 1 |
| Dalton, JF | 1 |
| Marshall, D | 1 |
| Raymond, LW | 1 |
| Kaplan, RL | 1 |
| Muggia, FM | 1 |
| Stillerman, R | 1 |
| Sweet, DL | 1 |
| Shah, S | 1 |
| Shane, SR | 1 |
| Barker, M | 1 |
| Deen, DF | 1 |
| Baker, DG | 1 |
| Kubanek, B | 1 |
| Bailey, CC | 1 |
| Marsden, HB | 1 |
| Jones, PH | 1 |
| Crittenden, D | 1 |
| Tranum, BL | 1 |
| Haut, A | 1 |
| Holoye, PY | 1 |
| Jenkins, DE | 1 |
| Greenberg, SD | 1 |
| Massin, F | 1 |
| Coudert, B | 1 |
| Foucher, P | 1 |
| Lombard, JN | 1 |
| Reybet-Degat, O | 1 |
| Jeannin, L | 1 |
| Camus, P | 1 |
| Twohig, KJ | 1 |
| Matthay, RA | 1 |
| Taylor, PM | 2 |
| Hasleton, PS | 2 |
| Lynch, P | 1 |
| Webster, A | 1 |
| Kalra, SJ | 1 |
| Gattamaneini, HR | 1 |
| Poulter, LW | 2 |
| Gattameneni, HR | 1 |
| Limper, AH | 1 |
| McDonald, JA | 1 |
| White, JP | 1 |
| Ward, MJ | 1 |
| Gaetani, P | 1 |
| Silvani, V | 1 |
| Butti, G | 1 |
| Spanu, G | 1 |
| Rossi, A | 1 |
| Knerich, R | 1 |
| Phillips, GL | 1 |
| Reece, DE | 1 |
| Lee, YC | 1 |
| Vetter, N | 1 |
| Berger, E | 1 |
| Otupal, I | 1 |
| Jürgenssen, OA | 1 |
| Schuller, HM | 1 |
| Smith, AC | 1 |
| Gregg, M | 1 |
| Boyd, MR | 1 |
5 reviews available for carmustine and Pulmonary Fibrosis
| Article | Year |
|---|---|
Review: diagnosis of chemotherapy lung.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Busulfan; Carmustine; Cy | 1981 |
[Nitrosourea-induced lung diseases].
Topics: Adult; Brain Neoplasms; Carmustine; Child; Drug Therapy, Combination; Female; Humans; Iatrogenic Dis | 1992 |
Pulmonary effects of cytotoxic agents other than bleomycin.
Topics: Antineoplastic Agents; Bleomycin; Busulfan; Carmustine; Cyclophosphamide; Humans; Lomustine; Methotr | 1990 |
Drug-induced adverse pulmonary reactions.
Topics: Amiodarone; Asthma; Bleomycin; Carmustine; Drug-Related Side Effects and Adverse Reactions; Gold; Hu | 1985 |
Clinical studies of autologous bone marrow transplantation in Hodgkin's disease.
Topics: Alkylating Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marro | 1986 |
2 trials available for carmustine and Pulmonary Fibrosis
| Article | Year |
|---|---|
Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 1997 |
Nitrosourea derivatives-induced pulmonary toxicity in patients treated for malignant brain tumors. Early subclinical detection and its prevention.
Topics: Adult; Aged; Ambroxol; Brain Neoplasms; Bromhexine; Carmustine; Clinical Trials as Topic; Double-Bli | 1987 |
45 other studies available for carmustine and Pulmonary Fibrosis
| Article | Year |
|---|---|
Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carmustine; Combined Modality Therapy; Disease-Free Surv | 2016 |
Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats.
Topics: Animals; Antineoplastic Agents, Alkylating; Carmustine; Collagen; Glutathione; Glutathione Reductase | 2009 |
Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation.
Topics: Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Breast Neoplasms; Carmustine; Drug A | 2003 |
Interferon-gamma for delayed pulmonary toxicity syndrome resistant to steroids.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Pro | 2003 |
Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-beta1 and cyclooxygenase-2.
Topics: Adult; Antineoplastic Agents, Alkylating; Carmustine; Cyclooxygenase 2; Fatal Outcome; Female; Human | 2004 |
25-year study of lung fibrosis following carmustine therapy for brain tumor in childhood.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Child; Disease Pr | 2004 |
The pulmonary toxicity of antineoplastic agents.
Topics: Age Factors; Aged; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bleomycin; Busul | 1982 |
Chemotherapy-induced pulmonary toxicity in mice bearing L1210 leukemia.
Topics: Animals; Antineoplastic Agents; Carmustine; Cyclophosphamide; Doxorubicin; Leukemia L1210; Lung Dise | 1983 |
The nitrosoureas and pulmonary toxicity.
Topics: Adolescent; Adult; Aged; Animals; Antineoplastic Agents; Carmustine; Child; Child, Preschool; Dogs; | 1981 |
Enhanced oxygen toxicity following treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Topics: Animals; Carmustine; Glutathione; Glutathione Reductase; Lethal Dose 50; Lung; Mice; Mice, Inbred BA | 1984 |
Chemotherapy-induced fatal pulmonary fibrosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child, Preschool; Epend | 1984 |
Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia.
Topics: Adult; Carmustine; Female; Humans; Leukemia, Myeloid; Lomustine; Male; Nitrosourea Compounds; Pulmon | 1983 |
[Fatal pulmonary fibrosis induced by cytotoxic therapy].
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Child; Child, Preschool; Ependymoma; Female; Hum | 1984 |
BCNU (1,3-bis-(2-chloroethyl)-1-nitrosurea) lung. Drug-induced pulmonary changes.
Topics: Adult; Astrocytoma; Brain Neoplasms; Carmustine; Humans; Lung; Lung Diseases; Male; Pulmonary Fibros | 1984 |
Fatal pneumothorax in "BCNU lung".
Topics: Adult; Astrocytoma; Brain Neoplasms; Carmustine; Female; Frontal Lobe; Humans; Parietal Lobe; Pneumo | 1982 |
1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced pulmonary fibrosis.
Topics: Adolescent; Adult; Aged; Biopsy; Brain Neoplasms; Carmustine; Female; Glioma; Humans; Lung; Male; Mi | 1980 |
Failure of corticosteroids to prevent carmustine-induced pulmonary fibrosis in a woman with astrocytoma.
Topics: Adrenal Cortex Hormones; Adult; Astrocytoma; Brain Neoplasms; Carmustine; Female; Frontal Lobe; Huma | 1981 |
[Interstitial pulmonary fibrosis following treatment with bis-chloronitrosourea].
Topics: Carmustine; Humans; Male; Middle Aged; Pulmonary Fibrosis | 1981 |
Pulmonary fibrosis: a complication of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
Topics: Brain Neoplasms; Carmustine; Child, Preschool; Humans; Medulloblastoma; Pulmonary Fibrosis; Risk | 1981 |
Pulmonary fibrosis following low-dose 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) therapy.
Topics: Aged; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Melanoma; Middle Aged | 1980 |
Rapidly progressive, fatal pulmonary fibrosis induced by carmustine.
Topics: Astrocytoma; Brain Neoplasms; Carmustine; Female; Humans; Lung; Middle Aged; Postoperative Care; Pul | 1980 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 41-1980.
Topics: Astrocytoma; Carmustine; Cerebellar Neoplasms; Child, Preschool; Diagnosis, Differential; Female; Hu | 1980 |
Late carmustine lung fibrosis. Age at treatment may influence severity and survival.
Topics: Adolescent; Age Factors; Brain Neoplasms; Carmustine; Child; Child, Preschool; Follow-Up Studies; Hu | 1995 |
Carmustine toxicity presenting as a lobar infiltrate.
Topics: Adult; Brain Neoplasms; Carmustine; Female; Glioma; Humans; Pulmonary Fibrosis; Vital Capacity | 1993 |
Carmustine and the lungs .
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Child; Female; Hodgkin Disease; Huma | 1997 |
[Progressive pulmonary fibrosis due to combined treatment with BCNU, cyclophosphospahmide and cytosin-arabinoside (author's transl)].
Topics: Carmustine; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; Middle Aged; Pu | 1978 |
Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU).
Topics: Adolescent; Adult; Aged; Carmustine; Cough; Dyspnea; Female; Humans; Hypoxia; Lymphoma; Male; Middle | 1979 |
Pulmonary toxicity of bischloronitrosourea: report of a case with transient response to corticosteroid therapy.
Topics: Carmustine; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prednisone; Pulmonary Fibrosis; Radiogr | 1979 |
Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU)
Topics: Carmustine; Humans; Pulmonary Fibrosis | 1979 |
Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU)
Topics: Carmustine; Humans; Pulmonary Fibrosis | 1979 |
Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU)
Topics: Antineoplastic Agents; Carmustine; Drug Therapy, Combination; Humans; Pulmonary Fibrosis | 1979 |
Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU)
Topics: Antineoplastic Agents; Carmustine; Drug Therapy, Combination; Humans; Pulmonary Fibrosis | 1979 |
Pulmonary toxicity from carmustine (BCNU): a case report.
Topics: Autopsy; Brain Neoplasms; Carmustine; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Meta | 1979 |
BCNU and X-ray therapy of intracerebral 9L rat tumors.
Topics: Animals; Brain Neoplasms; Carmustine; Male; Neoplasms, Experimental; Pulmonary Fibrosis; Radiation I | 1979 |
[Progressive pulmonary fibrosis during combination chemotherapy with BCNU (author's transl)].
Topics: Acute Disease; Carmustine; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; | 1978 |
Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
Topics: Carmustine; Cerebellar Neoplasms; Female; Humans; Infant; Medulloblastoma; Pneumonia, Pneumococcal; | 1978 |
Pulmonary fibrosis after prolonged therapy with 1,3-bis (2-chloroethyl)-1-nitrosourea.
Topics: Adult; Carmustine; Drug Therapy, Combination; Humans; Hydroxyurea; Imidazoles; Male; Melanoma; Pulmo | 1977 |
Pulmonary toxicity in long-term administration of BCNU.
Topics: Adult; Brain Neoplasms; Carmustine; Humans; Male; Pulmonary Fibrosis | 1976 |
Chronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features.
Topics: Carmustine; Central Nervous System Neoplasms; Child; Humans; Pulmonary Fibrosis; Time Factors; Tomog | 1991 |
Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma.
Topics: Astrocytoma; Biopsy; Brain Neoplasms; Carmustine; Ependymoma; Humans; Lung; Medulloblastoma; Microsc | 1991 |
Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.
Topics: Acute Disease; Adolescent; Brain Neoplasms; Carmustine; Child; Female; Humans; Lung; Male; Pulmonary | 1990 |
Delayed pulmonary fibrosis after nitrosourea therapy.
Topics: Carmustine; Humans; Pulmonary Fibrosis; Time Factors | 1990 |
Pulmonary hydroxyproline content and production following treatment of mice with O,S,S-trimethyl phosphorodithioate.
Topics: Animals; Carmustine; Hydroxyproline; Lung; Male; Mice; Mice, Inbred BALB C; Organothiophosphates; Or | 1987 |
[Recurrent bilateral pneumothorax in progressive lung fibrosis following combination therapy with BCNU].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cerebellar Neoplasms; Humans; Mal | 1985 |
Sequential pathological changes induced in rats with the anti-cancer drug I, 3-bis (2-chloroethyl)-I-nitrosourea (BCNU).
Topics: Animals; Blood Vessels; Bronchi; Carmustine; Collagen; Cytoplasm; Endoplasmic Reticulum; Endothelium | 1985 |